The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Characterization of the genomic alterations in poorly differentiated thyroid cancer

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC, identified using LC-SCRUM-Asia genomic screening platform -A step further to precision medicine

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study, BMC Pulmonary Medicine

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer, World Journal of Surgical Oncology

IJMS, Free Full-Text

Biomolecules, Free Full-Text

IJMS, Free Full-Text

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates - Sentana-Lledo - Translational Lung Cancer Research

Frontiers LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study, BMC Pulmonary Medicine

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities